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INTRODUCTION 
Visual impairment affects more than 161 million people worldwide. 
Current data derived from recent studies shows that 37 million were 
blind and 124 million people present with low vision, excluding tho­
se visually impaired due to uncorrected refractive errors(1,2). Taking 
into account the population growth and increased life expectancy 
there would be 76 million blind people by 2020, if attention does 
not improve(3). 
Uveitis consists of a large group of diseases characterized by intrao­
cular inflammation involving the uveal tract and has become increa­
singly recognized as one of the major cause of treatable blindness and 
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RESUMO
Objetivo: Identificar a frequência e as causas de uveítes que resultam em deficiência 
visual, em pacientes encaminhados ao Serviço de Visão Sub-Normal do Departamento 
de Oftalmologia - UNIFESP, durante um período de 20 anos.
Métodos: Em um estudo retrospectivo foram revisados 5.461 prontuários. Foram 
coletados os dados da primeira avaliação clínica realizada no Setor de Visão Sub-
Nor mal, que inclui idade do paciente, sexo e a causa da deficiência visual. Os registros 
clínicos dos pacientes com diagnóstico de uveíte foram revisados para classificação 
anatômica e diagnóstico.
Resultados: A média de idade dos pacientes encaminhados para o Setor de Visão 
Sub-Normal foi de 42.86 anos e a média de idade dos pacientes com diagnóstico 
de uveíte foi de 25.51 anos. As doenças retinianas foram as causas mais comuns de 
deficiência visual (N=2.835 pacientes; 51.9%), seguida por uveítes (N=862 pacientes, 
15.7%). Foi observado uveíte posterior em 792 pacientes (91.9% dos casos de uveíte) 
e, dentre estes, toxoplasmose foi o diagnóstico mais comum (765 pacientes, 88.7%).
Conclusões: Em nosso estudo, uveíte representa a segunda causa de deficiência visual 
nos pacientes encaminhados para reabilitação visual e retinocoroidite por toxoplasmose 
foi o diagnóstico clínico mais comum. Uveíte afeta uma população jovem e em idade 
laboral, portanto com relevante impacto social e econômico, mas o diagnóstico e 
tratamento precoce podem melhorar a qualidade de vida destes pacientes. 
Descritores: Pessoas com deficiência visual; Baixa de visão; Inflamação intraocular; 
Uveíte /epidemiologia
ocular morbidity worldwide, especially in the working­age population. 
It is a potentially blinding disorder accounting for 10­15% of all cases of 
total blindness in United States and up to 20% of legal blindness. Uvei­
tis and its complications are even more common in the developing 
world accounting for up to 25% of all causes of blindness(4­11). 
More than half of all patients with uveitis develop complications 
related to their disease, and up to 35% of patients end up with se­
vere visual impairment. Most of the studies do not consider uveitis 
as a cause of visual loss, but functional and anatomic complications 
secondary to uveitis are described as causes of visual impairment. In 
a hospital based survey of blindness in West Africa, in which these 
Visual impairment from uveitis in a reference hospital of Southeast Brazil: 
a retrospective review over a twenty years period
Deficiência visual em uveítes em hospital de referência da região sudeste do Brasil: 
uma revisão retrospectiva de 20 anos
Luci Meire Pereira da SiLva1, criStina MuccioLi2, FiLiPe de oLiveira2, tiago eugênio aranteS3, LucaS renó gonzaga4, céLia regina nakanaMi5
 Submitted for publication: May 20, 2013
 Accepted for publication: July 16, 2013
 Study carried out Universidade Federal de São Paulo - UNIFESP - São Paulo (SP), Brazil.
1 Clinical Research, Department of Ophthalmology, Universidade Federal de São Paulo - UNIFESP, 
São Paulo (SP), Brazil.
2 Physician, Department of Ophthalmology, Universidade Federal de São Paulo - UNIFESP - São 
Paulo (SP), Brazil.
3 Physician, Uveitis Section, Department of Ophthalmology, Universidade Federal de São Paulo - 
UNIFESP - São Paulo (SP), Brazil.
4 Academic of Medical Course, Escola Paulista de Medicina, Universidade Federal de São Paulo - 
UNIFESP - São Paulo (SP), Brazil.
5 Physician, Low Vision Service, Department of Ophthalmology, Universidade Federal de São Paulo 
- UNIFESP - São Paulo (SP), Brazil.
 Funding: No specific financial support was available for this study.
 Disclosure of potential conflicts of interest: L.M.P.Silva, None; C.Muccioli, None; F.Oliveira, None; 
T.E.Arantes, None; L.R.Gonzaga, None; C.R.Nakanami, None.
 Correspondence address: Luci Meire P. Silva. Rua Botucatu, 822 - 1o andar - São Paulo (SP) - 
04023-062 - Brazil - E-mail: luci.silva@unifesp.br
 Ethic Committee Registration - CEP/UNIFESP # 883/07
Silva LMP, et al.
367Arq Bras Oftalmol. 2013;76(6):366-9
sequelae were correctly attributed to uveitis, this disease was the 
second leading cause of blindness(6­8). Glaucoma, retinal detachment, 
cataract as well as macular scar are described as the most frequent 
causes of visual impairment in uveitic patients. 
Ocular toxoplasmosis, characterized by exudative retinochoroidal 
lesion and macular scars, is the most common cause of posterior 
uveitis in several countries and represents 60­85% of the posterior 
uveitis cases in Brazil and 25% in the United States and France. When 
compared to Europe and North America, Brazil has a disproportiona­
tely high incidence and severity of ocular toxoplasmosis(11­14). 
The purpose of the present study was to identify the frequency 
and causes of uveitis leading to visual impairment in patients referred 
to the Low Vision Service of the Department of Ophthalmology ­ 
 Federal University of São Paulo, over a twenty year period.
METHODS
A retrospective study was conducted in the Department of Oph ­
thalmology ­ Federal University of São Paulo (UNIFESP) and appro­
ved by the Institutional Review Board (IRB). Medical records of 461 
patients referred to the Low Vision Service over a twenty year period 
were reviewed. The data from the first clinical evaluation performed 
at the Low Vision Service were collected and included age, gender 
and diagnosis. All patients referred to this Service presented visual 
impairment, classified according to the World Health Organization 
(WHO), as a person who has impairment of visual functioning even 
after treatment and/or standard refractive correction, and has a visual 
acuity of less than 6/18 to light perception, or a visual field less than 10 
degrees from the point of fixation. WHO has published the term low 
vision as moderated visual impairment combined with severe visual 
impairment and both are according to the International Classification 
of Diseases ­ 10(15). According to the Low Vision Service requirements, 
all patients have had attended to these criteria to be evaluated by 
this service.
Patients seen from October 1987 to November 2007 were inclu­
ded in this study. Patients with uveitis had their chart reviewed for 
anatomical classification and clinical diagnosis. The classification 
criteria for uveitis were those defined by the International Uveitis 
Study Group(16). 
The distribution of continuous variables was expressed as mean ± 
standard deviation (SD) and categorical data were presented as abso­
lute and relative frequencies. Relationships between two categorical 
variables were assessed using Chi square test. Student t test and 
ANOVA were used for analysis of continuous variables. The statistical 
package SPSS 16.0 for Windows (SPSS, Inc, Chicago, Illinois, USA) was 
used in the analysis of the data.
RESULTS
A total of 5.461 patient´s charts were reviewed; the mean age 
of the group including all low vision patients was 42.86 years  (range 
from 0.25 to 104 years ­ SD 27.25). Patients with uveitis showed a 
mean age of 25.51 (range from 0.75 to 98 years ­ SD 21.17). The dif­
ference between gender was not statistically significant. Patient’s 
characteristics in both groups are summarized in table 1. 
Uveitis was the second most common cause of visual impairment 
(862 patients; 15.8%) and toxoplasmosis was the most frequent 
 clinical diagnosis in the uveitic group (765 cases; 88.7%), followed 
by Behçet disease (12 cases; 1.4%), Vogt­Koyanagi­Harada disease 
(11 cases; 1.3%), idiopathic choroiditis (10 cases; 1.2%), cytomegalo­
virus retinitis (9 cases; 1.0%), rubella (9 cases; 1.0%), Hansen´s disease 
(3 cases; 0.3%), sympathetic ophthalmia (3 cases; 0.3%), herpetic 
retinitis (2 cases; 0.2%), syphilis (2 cases; 0.2%), pars planitis (1 case; 
0.1%) and toxocariasis (1 case; 0.1%). Thirty four patients (3.9%) had 
uveitis of undetermined etiology and/or unavailable classification, as 
seen in the table 2.
According to the anatomical classification we found 792 (91.9%) 
posterior uveitis, 27 (3.1%) panuveitis, 3 (0.3%) anterior uveitis, 1 (0.1%) 
intermediate uveitis and 39 (4.5%) undetermined and/or not available 
classification. According to the etiological classification, 791 (91.8%) 
were infectious uveitis, 25 (2.9%) non­infectious uveitis, 12 (1.4%) non­in­
fectious associated with systemic disease and 34 (3.9%) undetermined 
uveitis and/or not available classification, as seen in the table 3.
Table 1. Patients characteristics – all patients x uveitic patients
All patients (N=5.461) Uveitic patients (N=862)
 N  % N  %
Gender
Male 2.439 44.7 411 047.7
Female 2.583 47.3 392 045.5
Not available 0.439 08.0 059 006.8
Total 5.461 862  100.0 100.0
Age
Mean ± SD (min­max) 42.86 ±27.25 (0.25­104) 25.51±21.27 (0.75­98)
Table 2. Principal causes of uveitis (N=862) / mean age (standard 
deviation)
Etiology/diagnosis N (%) Mean age (S D)
Toxoplasmosis 765 (88.7%) 24.17 (20.85)
Behçet´s disease 012 (01.4%) 40.91 (17.24)
Vogt­Koyanagi­Harada disease 011 (01.3%) 40.81 (24.28)
Idiopathic coroiditis 010 (01.2%) 50.40 (20.81)
Cytomegalovirus retinitis 009 (01.0%) 27.09 (19.30)
Rubeolla (congenital) 009 (01.0%) 10.11 (07.52)
Hansen´s disease 003 (00.3%) 64.33 (13.57)
Sympathetic ophthalmia 003 (00.3%) 30.00 (05.29)
Herpetic retinitis 002 (00.2%) 50.50 (33.23)
Sifilis 002 (00.2%) 40.00 (05.65)
Pars planitis 001 (00.1%) 39.00 (05.65)
Toxocariasis 001 (00.1%) 08.00 (05.65)
Undetermined uveitis/Not available 034 (03.9%) 35.81 (17.83)
Table 3. Distribution of uveitis by anatomical/etiological classifica-
tion (N=862)
N (%) 
Anatomical classification
Posterior 792 (91.9%)
Panuveitis 027 (03.1%)
Anterior 003 (00.3%)
Intermediate 001 (00.1%)
Undetermined/Not available 039 (04.5%)
Etiological classification
Infectious 791 (91.8%)
Non­infectious with no known systemic association 025 (02.9%)
Non­infectious with known systemic association 012 (01.4%)
Undetermined/Not available 0034 (03.9%)
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The frequency and distribution of visual impairment causes 
found from the 5.461 patients are presented in the table 4. Two 
hundred and sixty nine patients presented more than one cause of 
visual impairment, thus the total for the causes exceeds the overall of 
patients. The main causes of visual impairment were: retinal disorders 
(51.9%), uveitis (15.7%), refractive error (8.5%), optic atrophy (7.3%) 
and glaucoma (5.6%).  
DISCUSSION
We conducted an institutional­based retrospective study on 
5.461 medical charts of patients referred to the Low Vision Service 
of the Department of Ophthalmology ­ Federal University of São 
Paulo. We analyzed the characteristics of uveitis cases as well as its 
frequency in this population.
The patients referred to the Low Vision Service are those that 
require visual rehabilitation and training due to their impaired vision. 
The lack of visual acuity data does not prevent our goal that was to 
identify the frequency of visual impairment secondary to uveitis. This 
retrospective review is limited to the data from the first visit at the 
Low Vision Service, this study did not allow the clinical evaluation 
after the treatment and the visual prognosis.
A relatively equal distribution of male and female patients was 
observed in our uveitic group, as showed in most studies of different 
countries(11). In studies that report a gender difference, a male predo­
minance is more common in studies from developing countries. In 
studies from India was observed a male predominance higher than 
60%, but the reasons for this are unclear and may involve exposure 
patterns in agricultural societies or differences in the propensity to 
seek medical care. In the other hand, uveitis disorders affect men 
and women differently, and to analyze gender discrepancies are un­
doubtedly complex(11,17­21). 
Considering anatomic distribution, posterior uveitis was the most 
common with 792 cases (91,9%), being ocular toxoplasmosis the 
most common cause of uveitis (88.7%). As showed by London et al.(11) 
posterior uveitis is more common in the developing world due to a 
high prevalence of infectious causes, such as toxoplasmosis in Brazil, 
tuberculosis in India and onchocerciasis in Africa(10,14,20,22,23). Although 
limited data on the epidemiology of uveitis are available from Latin 
America, toxoplasmosis is considered to be the most frequent cause 
of posterior uveitis in most studies and an unusually high prevalence 
is reported in southern Brazil, probably related to genetic predis­
position, cultural factors such as agriculture­based economies and 
dietary habits(11­14). 
Our study revealed a frequency of posterior uveitis higher than 
in the studies reviewed by London et al.(11), but it is supported by 
Brazilian studies that showed uveitis as a main diagnosis observed 
in patients who are treated on visual rehabilitation clinics(24,25). Also 
being a tertiary referral centre, more patients are likely to suffer from 
severe visual impairment secondary to uveitis. In addition, as already 
reported by Rothova et al.(6), ocular toxoplasmosis was the most fre­
quent cause of both unilateral legal blindness and unilateral visual 
impairment.
 We found in the uveitic population a mean age of 25.51 years, 
characterizing a young working age population, this is supported by 
many others studies(7,8,10­14,24­27). With a majority of the patients in the 
working age group, the potential social and economic costs are enor­
mous but few data exist about visual morbidity caused by uveitis. The 
estimated cost of blindness to the United States economy from uvei­
tis is equal to the cost of blindness from diabetes which incidence is 
twice as high as uveitis(7,28). A study by the Royal National Institute for 
the Blind suggested that 34% of individuals lose jobs within two years 
of visual impairment(29). Two studies based on the Blue Mountains Eye 
Study cohort found that although bilateral visual morbidity results 
in reduced functional status and wellbeing that is comparable to a 
major medical condition, visual loss also have a measurable impact 
on quality of life(30,31). 
Considering the loss of reading ability is often considered to be 
the most devastating consequence of visual impairment in a young 
working age population, the development of rehabilitation tools 
is crucial to improve the vision of the uveitic patients. As found by 
Schmier et al., substantial differences exist in the use of services, de­
vices, and caregiving needs across levels of visual impairment among 
patients with diabetic retinopathy(32).
A limitation of our study is that the visual acuity scores of each 
case were not collected, however according to the Low Vision Servi­
ce requirements all patients have had attended the criteria a visual 
acuity of less than 6/18 to light perception, or a visual field less than 
10 degrees from the point of fixation. Most of these cases underwent 
developing strategies to optimize residual vision, however the visual 
rehabilitation data was not analysed by this study.
CONCLUSION
In our study, uveitis represents the second cause of visual im­
pairment among patients evaluated at the Low Vision Service of 
De partment of Ophthalmology/São Paulo Hospital/UNIFESP. The 
most common causes of low vision were retinal disorders followed 
by uveitis, refractive errors, optic atrophy, glaucoma e other causes. 
Toxoplasmosis is the most common cause of visual impairment in 
the uveitic group.
Taking in account that uveitis affects a young working age po­
pulation and shows a high prevalence in visual impaired patients, 
it should be considered as an important cause of visual loss with a 
relevant social and economic impact, but the early diagnosis and 
treatment can improve the quality of life of these patients.
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